» Articles » PMID: 37294757

Transcriptional Signatures of Heroin Intake and Relapse Throughout the Brain Reward Circuitry in Male Mice

Abstract

Opioid use disorder (OUD) looms as one of the most severe medical crises facing society. More effective therapeutics will require a deeper understanding of molecular changes supporting drug-taking and relapse. Here, we develop a brain reward circuit-wide atlas of opioid-induced transcriptional regulation by combining RNA sequencing (RNA-seq) and heroin self-administration in male mice modeling multiple OUD-relevant conditions: acute heroin exposure, chronic heroin intake, context-induced drug-seeking following abstinence, and relapse. Bioinformatics analysis of this rich dataset identified numerous patterns of transcriptional regulation, with both region-specific and pan-circuit biological domains affected by heroin. Integration of RNA-seq data with OUD-relevant behavioral outcomes uncovered region-specific molecular changes and biological processes that predispose to OUD vulnerability. Comparisons with human OUD RNA-seq and genome-wide association study data revealed convergent molecular abnormalities and gene candidates with high therapeutic potential. These studies outline molecular reprogramming underlying OUD and provide a foundational resource for future investigations into mechanisms and treatment strategies.

Citing Articles

Single-nucleus transcriptomics reveals time-dependent and cell-type-specific effects of psilocybin on gene expression.

Liao C, OFarrell E, Qalieh Y, Savalia N, Girgenti M, Kwan K bioRxiv. 2025; .

PMID: 39803502 PMC: 11722411. DOI: 10.1101/2025.01.04.631335.


Neuroinflammatory history results in overlapping transcriptional signatures with heroin exposure in the nucleus accumbens and alters responsiveness to heroin in male rats.

Floris G, Zanda M, Dabrowski K, Daws S Transl Psychiatry. 2024; 14(1):500.

PMID: 39702361 PMC: 11659471. DOI: 10.1038/s41398-024-03203-4.


An emerging multi-omic understanding of the genetics of opioid addiction.

Johnson E, Fisher H, Sullivan K, Corradin O, Sanchez-Roige S, Gaddis N J Clin Invest. 2024; 134(20).

PMID: 39403933 PMC: 11473141. DOI: 10.1172/JCI172886.


Serum cytokines and inflammatory proteins in individuals with heroin use disorder: potential mechanistically based biomarkers for diagnosis.

Butelman E, Huang Y, Cathomas F, Gaudreault P, Roussos P, Russo S Transl Psychiatry. 2024; 14(1):414.

PMID: 39362849 PMC: 11450096. DOI: 10.1038/s41398-024-03119-z.


How life events may confer vulnerability to addiction: the role of epigenetics.

Liu S, Harris A, Gewirtz J Front Mol Neurosci. 2024; 17:1462769.

PMID: 39359689 PMC: 11446245. DOI: 10.3389/fnmol.2024.1462769.


References
1.
Krueger S, Williams D . Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther. 2005; 106(3):357-87. PMC: 1828602. DOI: 10.1016/j.pharmthera.2005.01.001. View

2.
Jacobs E, Spijker S, Verhoog C, Kamprath K, de Vries T, Smit A . Active heroin administration induces specific genomic responses in the nucleus accumbens shell. FASEB J. 2002; 16(14):1961-3. DOI: 10.1096/fj.02-0272fje. View

3.
Fox M, Wulff A, Franco D, Choi E, Calarco C, Engeln M . Adaptations in Nucleus Accumbens Neuron Subtypes Mediate Negative Affective Behaviors in Fentanyl Abstinence. Biol Psychiatry. 2022; 93(6):489-501. PMC: 9931633. DOI: 10.1016/j.biopsych.2022.08.023. View

4.
Barbeira A, Dickinson S, Bonazzola R, Zheng J, Wheeler H, Torres J . Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat Commun. 2018; 9(1):1825. PMC: 5940825. DOI: 10.1038/s41467-018-03621-1. View

5.
. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014; 511(7510):421-7. PMC: 4112379. DOI: 10.1038/nature13595. View